Risk Reduction in Drug Discovery and Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|11|1087-1090

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.11, 2005-09, pp. : 1087-1090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychiatric Drug Discovery and Development

By Maubach Karen  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1571-1575

Informa Healthcare

Access to resources Recommend Favorite

Challenges of biomarkers in drug discovery and development

By Goodsaid Federico  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 6, 2012-06 ,pp. : 457-461

Informa Healthcare

Access to resources Recommend Favorite

Development of novel benzotriazines for drug discovery

By Palanki Moorthy SS   Cao Jianguo   Chow Chun P   Dneprovskaia Elena   Mak Chi Ching   McPherson Andrew   Pathak Ved P   Renick Joel   Soll Richard   Zeng Binqi   Noronha Glenn  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 33-49

Informa Healthcare

Access to resources Recommend Favorite

Drug Discovery and Development for Inflammatory Diseases

By Edwards III Carl K  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 151-163

Informa Healthcare

Access to resources Recommend Favorite

Protein kinases in drug discovery and development

By Gill A.  

Drug Discovery Today, Vol. 9, Iss. 1, 2004-01 ,pp. : 16-17

Elsevier

Access to resources Recommend Favorite